IGF2BP3 and neoplasm: Further analysis found lentiviral-mediated IGF2BP3 knockdown could overcome CDDP resistance in xenografts generated from T24R cells, as demonstrated by significantly reduced tumor growth in CDDP-treated xenografts than those without CDDP treatment (Fig. 7C).